Christina L Decatur

发表

PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma

Stefan Kurtenbach, Martine J Jager, S. Kurtenbach, 2016, Clinical Cancer Research.

BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas

Karam A. Alawa, J. Harbour, Matthew G. Field, 2019, Clinical Cancer Research.

Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.

A. Bowcock, J. Harbour, N. Garg, 2016, JAMA ophthalmology.

PieParty: visualizing cells from scRNA-seq data as pie charts

Stefan Kurtenbach, J. William Harbour, James J. Dollar, 2020, Life Science Alliance.

Genomic evolution of uveal melanoma arising in ocular melanocytosis

Sander R. Dubovy, Michael A. Durante, K. Covington, 2019, Cold Spring Harbor molecular case studies.

Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma.

J. Harbour, C. Decatur, B. Tarlan, 2018, American journal of ophthalmology.

Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas

Michael A. Durante, A. Bowcock, J. Harbour, 2016, Oncotarget.

Single-cell analysis reveals new evolutionary complexity in uveal melanoma

Michael A. Durante, J. Harbour, S. Kurtenbach, 2020, Nature Communications.

2-Deoxy-Glucose Downregulates Endothelial AKT and ERK via Interference with N-Linked Glycosylation, Induction of Endoplasmic Reticulum Stress, and GSK3β Activation

T. Lampidis, C. Decatur, J. Merchan, 2015, Molecular Cancer Therapeutics.

2-Deoxy-GlucoseDownregulates Endothelial AKT and ERK via Interference with N-Linked Glycosylation , Induction of Endoplasmic Reticulum Stress , and GSK 3 b Activation

T. Lampidis, C. Decatur, J. Merchan, 2016 .

2-DEOXY-GLUCOSE DOWN REGULATES ENDOTHELIAL AKT AND ERK VIA INTERFERENCE WITH N-LINKED GLYCOSYLATION, INDUCTION OF ENDOPASMIC RETICULUM STRESS AND GSK-3 β ACTIVATION INHIBITION OF ENDOTHELIAL AKT AND ERK BY

T. Lampidis, C. Decatur, Christina L Decatur, 2015 .

BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas

Anthony M. Cruz, J. Licht, K. Smalley, 2022, Cancers.

Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations.

Sander R. Dubovy, Michael A. Durante, J. Harbour, 2019, JAMA ophthalmology.

Intraocular Dissemination of Uveal Melanoma Cells Following Radiotherapy: Evolving Management Over the Past Decade.

Sander R. Dubovy, J. Harbour, C. Decatur, 2019, Ophthalmic surgery, lasers & imaging retina.

PRAME induces genomic instability in uveal melanoma

Anthony M. Cruz, Michael A. Durante, R. Shiekhattar, 2023, Research square.

The OA1 Autocrine Loop: in vivo and in vitro

D. Rice, B. McKay, A. Marmorstein, 2009 .

Punctuated evolution of canonical genomic aberrations in uveal melanoma

Michael A. Durante, A. Bowcock, J. Harbour, 2018, Nature Communications.

Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment

Nisha V. Shah, A. Markoe, W. Feuer, 2013, Clinical ophthalmology.

L-DOPA Is an Endogenous Ligand for OA1

C. Decatur, R. Lynch, W. Stamer, 2008, PLoS biology.

RB1 loss triggers dependence on ESRRG in retinoblastoma

Michael A. Durante, J. Harbour, Matthew G. Field, 2021, bioRxiv.

Analytical Validation and Performance of a 7-Gene Next-Generation Sequencing Panel in Uveal Melanoma

K. Covington, J. Harbour, F. Monzon, 2020, Ocular Oncology and Pathology.